NovaBay and Sonoma to market Avenova-branded products in EU through Sonoma’s distributor network
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Commenced operations in flood-affected Himachal Pradesh
Agreement provides customers in the majority of Europe* access to supply through Univar Solutions distribution network
Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe
New agreement applies to the polymers of the Medical Care series portfolio
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
The facility is over 79,000 square feet and is equipped with packaging lines
FedEx will be displaying a wide-range of effective healthcare packaging and specialized tracking technology
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
To focus on providing safer burn treatments for women and armed forces
Ties up with Denmark’s Vestfrost Solutions, to cater to the unique needs of the Indian market
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
The MOU provides for assistance in the form of efficient working Capital Management, development and commercialisation of new products, logistic supply chain management support etc.
Subscribe To Our Newsletter & Stay Updated